Physician profile
Bradley Wolf
NPI 1366486821
$31,998.11
in general payments reported to CMS, 2019-2025
23 companies · $6,138 in 2025
The $6,138 reported for 2025 was more than what 85% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,552 · 2020: $2,382 · 2021: $1,538 · 2022: $1,808 · 2023: $3,500 · 2024: $15K · 2025: $6,138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Consulting Fee: $9,000 · Travel and Lodging: $4,807 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,891.40 |
| Consulting Fee | $9,000.00 |
| Travel and Lodging | $4,806.92 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragonix Technologies, INC. | $9,000.00 | 2024 | |
| Endologix LLC | $6,843.00 | 2019-2025 | Alto Abdominal Stent Graft System, Afx2 Bifurcated Endograft System, Ovation Ix Iliac Stent Graft |
| Medtronic, INC. | $4,970.55 | 2021-2025 | Endurant Iis, Evera Mri Xt Dr Surescan, Corevalve Evolut R |
| Edwards Lifesciences Corporation | $2,488.96 | 2020-2025 | Evoque, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Atricure, INC. | $2,355.42 | 2019-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Artivion, INC. | $2,260.64 | 2023-2025 | Cryovalve Sg Pulmonary Human Heart Valve, Amds-Ascyrus Medical, Cardiac Non-Synergraft |
| Medtronic Vascular, INC. | $1,896.10 | 2019-2020 | |
| Abbott Laboratories | $633.33 | 2022-2025 | Mitraclip, Navitor, Epic |
| Abiomed | $574.77 | 2022-2025 | Impella |
| Silk Road Medical, INC. | $319.57 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Baxter Healthcare | $202.44 | 2020-2025 | Coseal |
| Cvrx, INC. | $113.17 | 2023-2024 | Barostim Neo System |
| Boston Scientific Corporation | $70.26 | 2019 | |
| W. L. Gore & Associates, INC. | $51.31 | 2019-2023 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Janssen Pharmaceuticals, INC | $44.38 | 2019-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $35.36 | 2019 | |
| Convatec INC. | $28.68 | 2023 | |
| Integra Lifesciences Corporation | $26.87 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Zimmer Biomet Holdings, INC. | $19.31 | 2020 | |
| Angiodynamics, INC. | $19.28 | 2025 | Auryon Laser System 100-120 Vac |
| Livanova USA, INC. | $16.61 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8.10 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.